Company Filing History:
Years Active: 2019
Title: The Innovations of Michael Lyman
Introduction
Michael Lyman is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His innovative work focuses on creating solutions that address critical health issues.
Latest Patents
Lyman holds a patent for "Antibody-fynomer conjugates." This invention features a bi-specific fusion polypeptide that includes a fynomer sequence binding to interleukin-17a (IL-17a). It is conjugated to an antibody or subsequence that binds to the interleukin-6 receptor (IL-6R). The fusion polypeptide is designed to bind to both IL-17a and IL-6R, effectively suppressing, reducing, decreasing, inhibiting, or blocking the activities of both IL-17a and IL-6R.
Career Highlights
Michael Lyman is currently employed at Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research and development efforts. His work has the potential to lead to significant breakthroughs in treating various diseases.
Collaborations
Lyman collaborates with notable colleagues, including Roland A Newman and Steve Granger. Their combined expertise enhances the innovative projects they undertake.
Conclusion
Michael Lyman's contributions to biotechnology through his patent on antibody-fynomer conjugates exemplify the impact of innovative thinking in addressing health challenges. His work at Mitsubishi Tanabe Pharma Corporation continues to pave the way for future advancements in the field.